Bora Pharmaceuticals acquires biologics CDMO facility
Bora says the acquisition will allow it to rapidly build a presence in the biopharmaceuticals market.
Taiwan-based CDMO Bora Pharmaceuticals has acquired assets from Eden Biologics to facilitate the company’s expansion into biopharmaceuticals.
The acquisition of the CDMO facility, located in Hsinchu Biomedical Science Park, Taiwan, will equip Bora with technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, the establishment of quality control and inspection specifications, as well as cell bank generation.
Speaking about the news, Bora Vice President Simon Chen said: ‘The addition of the CDMO facilities, equipment and the expertise of the highly qualified team gives Bora Biologics the ability to develop and continue with our clients as they progress to commercialisation.’
He noted that the facility contains four 500L bioreactors, all of which have been certified by the EU Qualified Person (QP) and the Taiwan Food and Drug Administration.
Bora Chairman Bobby Sheng added that the acquisition is an important milestone as the company continues to expand its presence in the CDMO market.
In December 2021 the company announced a partnership with Taishin Healthcare Limited Partnership, where the two parties would invest $108 million to expand its footprint in the CDMO sector and enter the macromolecular/cell and gene therapy manufacturing space.
The company recently announced the establishment of Bora Biologics to focus on this expansion. Alongside Taishin, Tanvex BioPharma founder Dr. Allen Chao is an investor.
Bora Pharmaceuticals is a CDMO specializing in a wide range of complex dosage forms including oral solid, liquid, and semi-solid capabilities for both Rx and OTC products, with facilities in Asia and North America.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance